000 01304 a2200349 4500
005 20250513185913.0
264 0 _c19990903
008 199909s 0 0 eng d
022 _a0301-5629
024 7 _a10.1016/s0301-5629(99)00017-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStrauss, A L
245 0 0 _aPersistent opacification of the left ventricle and myocardium with a new echo contrast agent.
_h[electronic resource]
260 _bUltrasound in medicine & biology
_cJun 1999
300 _a763-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAir
650 0 4 _aAnimals
650 0 4 _aContrast Media
_xadministration & dosage
650 0 4 _aDogs
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aEchocardiography
_xinstrumentation
650 0 4 _aFluorocarbons
_xadministration & dosage
650 0 4 _aHeart Ventricles
_xdiagnostic imaging
650 0 4 _aInjections, Intravenous
650 0 4 _aPhosphatidylcholines
_xadministration & dosage
650 0 4 _aTime Factors
700 1 _aBeller, K D
773 0 _tUltrasound in medicine & biology
_gvol. 25
_gno. 5
_gp. 763-9
856 4 0 _uhttps://doi.org/10.1016/s0301-5629(99)00017-4
_zAvailable from publisher's website
999 _c10372953
_d10372953